This has since been renamed as graft-versus-host-disease (GVHD) and understood to occur due to donor T lymphocytes reacting to MHC molecules of the recipient, inducing a hyperinflammatory immune response and system-wide tissue damage (154, 155). The gene discussed is HLA-C; the disease is graft versus host disease.